<DOC>
	<DOCNO>NCT02907632</DOCNO>
	<brief_summary>Gastroesophageal Reflux ( GER ) condition affect majority premature infant follow Kangaroo Mother Care Program ( ambulatory program preterm infant discharge mother continuous skin skin contact strict outpatient follow ) . For 20 year , use Metoclopramide systematic among preterm infant accord protocol Kangaroo Mother Care ( KMC ) Program . The aim clinical trial evaluate effectiveness security metoclopramide lessen symptom GRE premature infant follow treated Ambulatory KMC Program 40 week gestational age . Design : Randomized , double blind trial , control placebo . Eligible Population : Premature infant follow treated Ambulatory Kangaroo Mother Care Program Hospital Universitario San Ignacio 40 week gestational age , systematically receive : metoclopramide 0.2 mg per kg , every 8 hour , 15 minute every feed 40 week gestational age , January 01 2017 December 31 2017.Outcomes : Incidence regurgitation episode report parent infant , episode apnea , bronchoaspiration , postprandial irritability , infant reject feed , alteration postprandial posture frequency severity adverse effect associate use Metoclopramide extrapyramidal symptom sedation . In case continuous variable , mean median compare accord distribution nominal variable , chi square test fisher test carry . Duration : 12 month . Ethical Aspects : Experiment minimum mayor risk . Informed consent request parent . An independent committee work group charge carry follow-up safety progression study . A methodological expert , thematic expert , statistician expert bioethics constitute committee . Financial Disclosure : The study fund Kangaroo Foundation collaboration `` Hospital Universitario San Ignacio '' , Bogotá , Colombia .</brief_summary>
	<brief_title>Methoclopramide Gastroesophageal Reflux Premature Infants</brief_title>
	<detailed_description>Justification : Gastroesophageal Reflux ( GER ) condition affect majority premature infant follow Kangaroo Mother Care Program . The incidence GRE premature infant oscillate 22 85 % depend criterion use diagnose GER , vary among healthcare professional . For 20 year , use metoclopramide systematic among preterm infant accord protocol Kangaroo Mother Care ( KMC ) Program . These protocol establish accord recommendation emit Cochrane Collaboration 2006 , nevertheless accord new study publish last year , controversial evidence refer use metoclopramide give eventual possibility adverse effect lack evidence premature infant , necessary evaluate whether pertinent continue use metoclopramide premature infant risk adverse effect . Objective : To evaluate effectiveness security metoclopramide lessen symptom GRE premature infant follow treated Ambulatory KMC Program 40 week gestational age . Design : Randomized , double blind trial , control placebo . Eligible Population : Premature infant follow treated Ambulatory KMC Program Hospital Universitario San Ignacio 40 week gestational age , systematically receive : metoclopramide 0.2 mg per kg , every 8 hour , 15 minute every feed 40 week gestational age , January 01 2017 December 31 2017 . Intervention : Blind randomize allocation experimental treatment ( metoclopramide 0.2 mg per kg , every 8 hour , 15 minute every feed 40 week gestational age ) placebo . Outcomes : Incidence regurgitation episode report parent infant , episode apnea , bronchoaspiration , postprandial irritability , infant reject feed , alteration postprandial posture frequency severity adverse effect associate use metoclopramide extrapyramidal symptom sedation . In case continuous variable , mean median compare accord distribution nominal variable , chi square test fisher test carry out.Intervention : Blind randomize allocation experimental treatment ( metoclopramide 0.2 mg per kg , every 8 hour , 15 minute every feed 40 week gestational age ) placebo . Expected Results : Reliable information regard use metoclopramide premature infant prevention regurgitation episode associate apnea , cyanosis , irritability , rejection feeding effort , bronchoaspiration poor weight gain well adverse effect . Duration : 12 month . Ethical Aspects : Experiment minimum mayor risk . Informed consent request parent . An independent committee work group charge carry follow-up safety progression study . A methodological expert , thematic expert , statistician expert bioethics constitute committee . Financial Disclosure : The study fund Kangaroo Foundation collaboration `` Hospital Universitario San Ignacio '' , Bogota , Colombia .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Metoclopramide</mesh_term>
	<criteria>Preterm infant follow ambulatory Kangaroo Mother Care Program ( KMCP ) Hospital San Ignacio , Bogotá , Colombia . Hipoxic Ischemic Encephalopathy . Periventricular Leukomalacia ( PVL ) . Intraventricular hemorrhage grade 3 4 . Severe dystonia Seizures . Liver failure . Renal insufficiency . Previous adverse event use Metoclopramide . Parents don´t agree participation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>100 Days</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Metoclopramide</keyword>
	<keyword>Pro kinetic</keyword>
	<keyword>Gastroesophageal Reflux</keyword>
	<keyword>Premature Infant</keyword>
	<keyword>Low Birth Weight</keyword>
	<keyword>Kangaroo Mother Care Method</keyword>
</DOC>